[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353938-105":59,"doc-detail-353938-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-mirna-biomarkers-and-development-of-predictive-signatures-for-early-detection-and-prognosis-in-cervical-precancer-and-cancer","Identification of miRNA biomarkers and development of predictive signatures for early detection and prognosis in cervical precancer and cancer","","Aberrant microRNA expression is linked to cervical carcinogenesis, making miRNAs attractive biomarkers for early detection and risk stratification. This study identifies and validates miRNA expression profiles that separate benign, precancer, and invasive cancer cervical tissues, supporting their use in screening and diagnosis. Archival FFPE tissues from 272 women were sequenced, differential expression and target enrichment were modeled, and predictive signatures were built with machine learning and survival assessment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-mirna-biomarkers-and-development-of-predictive-signatures-for-early-detection-and-prognosis-in-cervical-precancer-and-cancer/353938/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-mirna-biomarkers-and-development-of-predictive-signatures-for-early-detection-and-prognosis-in-cervical-precancer-and-cancer/353938.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biological rationale supports using miRNAs for cervical cancer biomarkers?","Question",{"text":112,"@type":113},"Aberrant microRNA expression is implicated in cervical carcinogenesis, and miRNAs regulate gene expression processes relevant to cancer development. Their dysregulation has been associated with initiation and progression across cancers, including cervical cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were miRNA expression profiles measured and analyzed?",{"text":117,"@type":113},"MiRNA expression was analyzed from archival FFPE cervical tissues of 272 women using next-generation sequencing. Differential expression used DESeq2 with criteria of absolute log2 fold change ≥ 1 and adjusted p-value \u003C 0.05, followed by enrichment and PPI network analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What predictive models and miRNA signatures were developed, and how were they validated?",{"text":121,"@type":113},"Machine learning classifiers were trained using recursive feature elimination and XGBoost, producing a 26-miRNA panel for multiclass classification and a 4-miRNA panel for binary classification of cancer vs benign. The binary model showed strong performance with AUC values reported for internal and external validation sets, and both signatures related to overall survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353938,1790726020,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","Onyenobi etal. Human Genomics (2026) 20:60 Human Genomics  \n[https://doi.org/10.1186/s40246-026-00924-z](https://doi.org/10.1186/s40246-026-00924-z)  \nRESEARCH Open Access  \nIdentification of miRNA biomarkers and development of predictive signatures for early detection and prognosis in cervical precancer and cancer  \nEbuka Onyenobi 1, Michael Zhong 1, Josephine Peitz 1,2, Kiranpreet Chawla3, Amy Plotkin4, Clement Adebamowo 1,5 and Sally N. Adebamowo 1,5*  \nAbstract  \nBackground Aberrant microRNA expression has been implicated in cervical carcinogenesis, making miRNAs promising biomarkers for early detection and risk stratification of cervical precancer and cancer. This study aimed to identify and validate miRNA expression profiles and signatures that distinguish benign, precancer, and cancer cervical tissues, providing insights into their potential utility in cervical cancer screening and diagnosis.  \nMethods We analyzed miRNA expression from archival FFPE cervical tissues of 272 women (100 benign, 89 precancer, 83 invasive cancer) using next-generation sequencing. Differential expression was assessed using DESeq2 with significant miRNAs defined by an absolute log2 fold change ≥ 1 and an adjusted p-value \u003C 0.05. Functional enrichment of miRNA targets was performed using multiMiR and DAVID, and protein-protein interaction (PPI) networks were constructed using STRING and Cytoscape. Machine learning classifiers were developed with recursive feature elimination (RFE) and XGBoost and evaluated in internal and external cohorts. miRNA signatures were further assessed for association with overall survival in theTCGA cervical cancer cohort using multivariable Cox regression models.  \nResults Notably, hsa-miR-1246 was the most significant miRNA in cancer vs. benign (log₂ FC = 5 . 58, p = 3.20 × 10 41) and cancer vs. precancer (log₂ FC = 4 . 89, p = 5.23 × 10 33) . hsa-miR-149-5p was most significant in benign vs. precancer (log₂ FC = −1 .48, p = 1.53 × 10 ⁻ ¹⁴) . Enrichment analyses highlighted cancer-related pathways with hub genes including TP53, BCL2, STAT3, ESR1, and MYC. RFE with XGBoost identified a 26-miRNA panel for multiclass classification and a 4-miRNA panel for binary cancer vs. benign classification. The binary model achieved strong performance with an AUC of 0.97 and 0.91 in internal and external validation sets respectively. Both the 26-miRNA (p \u003C 0. 001) and 4-miRNA (p = 0 . 01) signatures were associated with poorer overall survival.  \nConclusion Our findings identify distinct miRNAs and miRNA-based signatures that differentiate benign, precancer, and cancer cervical tissues, highlighting their potential clinical utility as diagnostic and prognostic biomarkers.  \n*Correspondence:  \nSally N. Adebamowo[sadebamowo@som. umaryland.edu](sadebamowo@som. umaryland.edu)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nOnyenobi et al. Human G","cbCaioF32aqgLGaV","https://ap.wps.com/l/cbCaioF32aqgLGaV","pdf",2969630,13,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What biological rationale supports using miRNAs for cervical cancer biomarkers?\",\"answer\":\"Aberrant microRNA expression is implicated in cervical carcinogenesis, and miRNAs regulate gene expression processes relevant to cancer development. Their dysregulation has been associated with initiation and progression across cancers, including cervical cancer.\"},{\"question\":\"How were miRNA expression profiles measured and analyzed?\",\"answer\":\"MiRNA expression was analyzed from archival FFPE cervical tissues of 272 women using next-generation sequencing. Differential expression used DESeq2 with criteria of absolute log2 fold change ≥ 1 and adjusted p-value \\u003c 0.05, followed by enrichment and PPI network analyses.\"},{\"question\":\"What predictive models and miRNA signatures were developed, and how were they validated?\",\"answer\":\"Machine learning classifiers were trained using recursive feature elimination and XGBoost, producing a 26-miRNA panel for multiclass classification and a 4-miRNA panel for binary classification of cancer vs benign. The binary model showed strong performance with AUC values reported for internal and external validation sets, and both signatures related to overall survival.\"}]","Identification of miRNA biomarkers and development of predictive signatures for early detection and prognosis in cervical precancer and cancer | PDF",1790108068,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/31b305ddcde6c05fde42bc296dd86218.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10c4326a2ad759c64ad0386e6381346a.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f5aa036db1379dea6022b9e1f82e3ac.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c047020a026e97c651441b94953dcd38.webp",980,1306]